The tumor volume in PC-9 (Del 19, EGFR sensitive mutation) or NCI-H1975 (L858R/T790M resistance mutation) xenograft model showed a significant reduction, indicating that SH-1028 could inhibit tumor growth in a dose-dependent manner. Here, EGFR is linked to neoplasm.